Hydroxychloroquine Oral Tablet

DRUG6 trials

Sponsors

Assiut University, National University of Malaysia, Centre Hospitalier Universitaire de Saint Etienne, Yunfeng Cheng

Conditions

Autoimmune DiseasesDiabetes in PregnancyIgA NephropathyImmune Thrombocytopenia With Positive ANA AntibodiesType 2 Diabetes

Phase 2

Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study

Not yet recruitingNCT06350630

Centre Hospitalier Universitaire de Saint EtienneIgA Nephropathy

Start: 2025-06-30End: 2030-12-31Target: 334Updated: 2025-06-05

Unknown Phase

Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine)

Assiut UniversityAutoimmune Diseases

Start: 2017-06-28End: 2018-07-28Target: 50Updated: 2017-06-09

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

RecruitingNCT06319560

National University of MalaysiaDiabetes in Pregnancy, Type 2 Diabetes

Start: 2024-03-24End: 2027-01-01Target: 56Updated: 2025-06-12

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

RecruitingNCT06479291

Yunfeng ChengImmune Thrombocytopenia With Positive ANA Antibodies

Start: 2024-07-31End: 2026-12-31Target: 126Updated: 2024-06-28

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

RecruitingNCT06479317

Yunfeng ChengImmune Thrombocytopenia With Positive ANA Antibodies

Start: 2024-04-24End: 2026-12-31Target: 129Updated: 2024-06-28

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

RecruitingNCT06479304

Yunfeng ChengImmune Thrombocytopenia With Positive ANA Antibodies

Start: 2024-04-24End: 2026-12-31Target: 129Updated: 2024-06-28

Related Papers

Hydroxychloroquine as an adjunct therapy in the management of type 2 diabetes in pregnancy: study protocol for a randomised controlled trial.

2026-01-20